Literature DB >> 20591487

Incidence of glaucomatous visual field loss: a ten-year follow-up from the Rotterdam Study.

Monika A Czudowska1, Wishal D Ramdas, Roger C W Wolfs, Albert Hofman, Paulus T V M De Jong, Johannes R Vingerling, Nomdo M Jansonius.   

Abstract

PURPOSE: To determine the 10-year incidence of glaucomatous visual field loss (GVFL) and to investigate the influence of risk factors for open-angle glaucoma on this incidence.
DESIGN: Population-based cohort study. PARTICIPANTS: Participants aged > or =55 years from the Rotterdam Study.
METHODS: Of the 7983 participants in the Rotterdam Study, 6806 underwent ophthalmic examinations at baseline (1990-1993). In 6723 of these 6806 participants (99%), both visual field screening and an assessment of the optic disc were performed. After exclusion of 93 participants with GVFL at baseline, 6630 participants at risk of developing GVFL remained. These participants underwent similar ophthalmic examinations during 2 follow-up visits (1997-1999 and 2002-2006). The incidence of GVFL was determined as an incidence rate and recalculated to a 10-year risk. Risk factors for open-angle glaucoma (age, gender, positive family history of glaucoma, baseline intraocular pressure (IOP), myopia, and baseline vertical cup-to-disc ratio [VCDR]) were assessed using Cox regression. The dependent variable was the development of GVFL. MAIN OUTCOME MEASURES: Ten-year risk and incidence rates of GVFL. Hazard ratios of the above-mentioned risk factors.
RESULTS: Of 6630 participants, 3939 (59%) completed at least 1 follow-up examination and 2571 (39%) completed both; 108 participants developed GVFL. The overall incidence rate and 10-year risk of GVFL were 2.9 per 1000 person-years (95% confidence interval [CI], 2.4-3.5) and 2.8% (2.3-3.4), respectively. The 10-year risk increased from 1.9% at age 55 to 59 years to 6.4% at age > or =80 years (P<0.001). The incidence increased by 11% per millimeter of mercury increase in IOP (hazard ratio 1.11; 95% CI, 1.06-1.15). Male gender (1.62; 1.10-2.38), high myopia (spherical equivalent < or =-4 D myopic; 2.31; 1.19-4.49), and a baseline VCDR above the 97.5th percentile (4.64; 2.72-7.91) were associated with the development of GVFL. A positive family history was only significantly associated with the development of GVFL if IOP was removed from the model (2.0; 1.2-3.3; P = 0.012).
CONCLUSIONS: These data provide an estimate of the incidence of GVFL in a white population. The development of GVFL was related to higher IOP, older age, high myopia, male gender, a positive family history of glaucoma, and a larger baseline VCDR.
Copyright © 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20591487     DOI: 10.1016/j.ophtha.2010.01.034

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  34 in total

1.  Central retinal artery resistive index and optical coherence tomography in assessment of glaucoma progression.

Authors:  Ahmed F Abdel Ghany; Samer M Botros; Tamer M El-Raggal
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

2.  Population-based evaluation of retinal nerve fiber layer, retinal ganglion cell layer, and inner plexiform layer as a diagnostic tool for glaucoma.

Authors:  Henriët Springelkamp; Kyungmoo Lee; Roger C W Wolfs; Gabriëlle H S Buitendijk; Wishal D Ramdas; Albert Hofman; Johannes R Vingerling; Caroline C W Klaver; Michael D Abràmoff; Nomdo M Jansonius
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-20       Impact factor: 4.799

3.  Association between myopia and glaucoma in the United States population.

Authors:  Mary Qiu; Sophia Y Wang; Kuldev Singh; Shan C Lin
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-28       Impact factor: 4.799

4.  Optimizing the information yield of 3-D OCT in glaucoma.

Authors:  Henriët Springelkamp; Kyungmoo Lee; Wishal D Ramdas; Johannes R Vingerling; Albert Hofman; Caroline C W Klaver; Milan Sonka; Michael D Abràmoff; Nomdo M Jansonius
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-13       Impact factor: 4.799

Review 5.  [Differentiation of ocular hypertension].

Authors:  E M Hoffmann; J Lamparter
Journal:  Ophthalmologe       Date:  2016-08       Impact factor: 1.059

Review 6.  [Assessment of risk factors for the occurrence of open angle glaucoma : Guidelines of the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany].

Authors: 
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

Review 7.  [Glaucoma treatment in high myopia].

Authors:  B Voykov; J M Rohrbach
Journal:  Ophthalmologe       Date:  2019-05       Impact factor: 1.059

8.  Clinical characteristics of glaucomatous subjects treated with refractive corneal ablation surgery.

Authors:  Kyung Rim Sung; Jin Young Lee; Myoung Joon Kim; Jung Hwa Na; Jae Yong Kim; Hung Won Tchah
Journal:  Korean J Ophthalmol       Date:  2013-02-27

9.  Automated Beta Zone Parapapillary Area Measurement to Differentiate Between Healthy and Glaucoma Eyes.

Authors:  Patricia Isabel C Manalastas; Akram Belghith; Robert N Weinreb; Jost B Jonas; Min Hee Suh; Adeleh Yarmohammadi; Felipe A Medeiros; Christopher A Girkin; Jeffrey M Liebmann; Linda M Zangwill
Journal:  Am J Ophthalmol       Date:  2018-05-09       Impact factor: 5.258

10.  Corticosteroids and open-angle glaucoma in the elderly: a population-based cohort study.

Authors:  Michael W Marcus; Rogier P H M Müskens; Wishal D Ramdas; Roger C W Wolfs; Paulus T V M De Jong; Johannes R Vingerling; Albert Hofman; Bruno H C Stricker; Nomdo M Jansonius
Journal:  Drugs Aging       Date:  2012-12       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.